STAT+: New data point to benefits of Bristol’s novel psoriasis pill, but safety issues will be scrutinized
Last November and then again in February, Bristol Myers Squibb said its oral drug designed…
Author: STAT
STAT+: Pharmalittle: CDC committee to vote on J&J Covid-19 vaccine; has the White House written off the J&J shot?
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Congress: stand up to the paper lobby and abolish outdated paper labeling for clinicians
There’s no place in health care for practices that fail to serve the best interests…
Opinion: Real-world data, not predictions, should drive decisions on Covid-19 and school opening
The United States has exceeded 31 million Covid-19 infections (a messy data point) and is…
States with springtime Covid-19 surges appear to have turned a corner
Michigan and other states that experienced springtime Covid-19 surges or faced worrisome transmission trends appear…
Could a souped-up version of existing Covid-19 tests be our shortcut to tracking variants?
Genomic sequencing is one of the best defenses against potentially deadlier or more transmissible variants…
Listen: The latest mask debate, FDA in limbo, & gene therapy’s uncertain upside
When can we stop wearing masks outside? Are we ever getting a permanent FDA commissioner?…
In mouse experiments, scientists unlock the key to scar-free skin healing
Scars. Like memories, we all have them. When you look at a scar you might…
STAT+: ‘There are no alternatives’: As Pfizer discontinues an old glaucoma drug, a small group of patients struggles to cope
Next month, an eye drop that Carol Vaghar has taken for the past few years…
Opinion: Academic medical centers need to go beyond statements condemning racism
As predictable as mushrooms popping up after rain, condemnation of racism from leaders at academic…
STAT+: Pharmalittle: Europe looks to sue AstraZeneca over Covid-19 vaccine shortfalls; FDA skewers Emergent vaccine facility
Hello, everyone, and how are you today? Cold winds are whipping about the Pharmalot campus,…
STAT+: With $12 million in new funding, data-syncing platform Seqster takes aim at health records
If health tech challenges were mountains, patient medical records would be a kind of Everest,…
Opinion: Climate change and human immunity: invest now or pay more later
World leaders, beckoned by President Biden, are assembling on Earth Day, April 22, to create…
Opinion: Needed for long Covid: a less authoritarian approach to understanding, treatment
The public has become increasingly concerned about long Covid — ongoing symptoms and disabilities after…
STAT+: Bluebird’s withdrawal of therapy from Germany could chill talks over gene therapy prices across Europe
When Bluebird Bio secured European approval for its gene therapy to treat beta thalassemia in…
A new crop of medical devices are trying to hack the vagus nerve to treat disease
The vagus nerve, also known as the “wandering nerve,” winds a path all around your…
STAT+: More surveillance is coming to the operating room. Surgeons warn that’s risky
Much of what happens in the operating room is shrouded in mystery: The patient goes…
.jpg)
STAT+: Worried drug pricing reform might be left behind, Democrat pushes Biden to make clear his support
WASHINGTON — At least one Democratic lawmaker is openly pushing President Biden to include drug…
STAT+: FDA issues scathing report of Emergent plant responsible for contaminated Covid-19 vaccines
The Food and Drug Administration issued a scathing inspection report of the Emergent BioSolutions (EBS)…
Opinion: Listen: A Baghdad-trained physician on the barriers to getting a medical license in the U.S.
In this episode of the First Opinion Podcast, I speak with Lubab al-Quraishi, a Baghdad-trained…
STAT+: Pharmalittle: Pfizer identifies first counterfeit versions of its Covid-19 vaccine; top house Democrats investigate Emergent BioSolutions
Rise and shine, everyone, another busy day is on the way. This is the middle…
Opinion: FDA: make medical apps reliable, not risky
The fear of Covid-19 catapulted symptom checkers from the periphery of public attention to the…
Opinion: Low-tech but high-value: Don’t stop reimbursing phone-only telehealth visits
At the start of the Covid-19 pandemic, the Centers for Medicare and Medicaid Services and…
STAT+: Why hospitals hate Bernie Sanders’ latest health reform push
WASHINGTON — Progressives in Congress, led by Sen. Bernie Sanders, have ramped up pressure on…
Most Americans say they should be vaccinated before the U.S. donates Covid-19 shots elsewhere
Three-quarters of Americans believe the U.S. government should start donating Covid-19 vaccines to other countries,…
‘No one was listening’: Long Covid patients struggle to get care for their symptoms
Last summer, in the six weeks after she began feeling terrifyingly breathless and was briefly…
STAT+: Congress probes Emergent’s ties to a key Trump official in wake of Covid-19 vaccine scandal
A pair of top House Democrats is investigating whether Emergent BioSolutions (EBS), which was responsible…
STAT+: Pfizer shareholders are urged to reject political spending that contradicts ‘company values’
Arguing that Pfizer’s political spending conflicts with the company’s publicly stated values, a philanthropic organization…
Top Senate Republican holds up Biden’s CMS nominee over Texas Medicaid waiver
WASHINGTON — A top Senate Republican is holding up the confirmation of President Biden’s nominee…
Opinion: For people of color, ‘where is our pause’ from being killed by police?
Each night, after our 7-year-old son falls asleep, my wife or I go into his…
STAT+: Beam Therapeutics unveils new CRISPR base editing tool to target the sickle cell mutation
Right now, trillions of donut-shaped red blood cells are whizzing through your arteries, ferrying oxygen…
STAT+: Pharmalittle: Biden aides met with U.S. health companies about supply chains; J&J Covid-19 shot notched $100m in sales
Hello, everyone, and how are you today? A shiny sun and delightful breeze are enveloping…
STAT+: STAT+ Conversations: A conversation on building infrastructure for population health
Editors note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Genetically targeted drug from Syndax Pharma shows remissions in leukemia patients
Syndax Pharmaceuticals said Tuesday that its genetically targeted cancer drug induced complete remissions in patients…
STAT+: The future of voice tech in medicine is here. Can reality live up to the promise?
Microsoft’s high-profile of acquisition of Nuance Communications is a seeming win for patients and providers….
Opinion: FTC’s challenge to Illumina’s vertical merger with Grail is all wrong
My mom died of stage 4 cancer in February 2008. Had the technology existed then…
Opinion: Catching Covid-19 after being vaccinated isn’t a myth. It happened to me
When I was vaccinated against Covid-19, I felt a deep sense of relief: no more…
A new book traces the roots of the opioid crisis through the secretive Sackler family
The family behind the OxyContin maker Purdue Pharma was already under intense legal and public…
STAT+: Biden officials met privately with 3M, AmerisourceBergen, PhRMA and more to debate shoring up the national stockpile
WASHINGTON — The Biden administration met privately this month with some of the nation’s biggest…
We know a lot about Covid-19. Experts have many more questions
Less than a year and a half ago, the world was blissfully, dangerously ignorant of…
STAT+: Adagio raises $336 million to advance Covid-19 antibody treatment
Waltham-based Adagio Therapeutics announced on Monday that it has raised $336 million in new funding…
STAT+: Pharmalittle: J&J denies design of its Covid-19 shot may explain blood clots; second trial against opioid makers begins
Good morning, everyone, and welcome to another working week. Once again, another delightful weekend respite…
STAT+: Advocacy groups outraged after PBM offers a $500 gift card to persuade patients to switch drugs
Dozens of patient advocacy groups are angry over an unusual move by a pharmacy benefits…
Opinion: STAT+: The FDA should embrace remote and automated drug inspection technology
While pharmaceutical regulatory authorities in other countries are employing creative ways like video-based remote inspections…
Opinion: For-profit nursing homes and hospices are a bad deal for older Americans
Nursing homes and hospice care are supposed to provide safe refuges for older people and…
STAT+: The lobbying juggernaut the American Hospital Association is losing its top advocate at a critical moment for the industry
WASHINGTON — Tom Nickels helped build the American Hospital Association into one of the biggest…
In Q&A, Vice President Harris calls for urgent action on the Black maternal health crisis
It’s an American crisis that was long ignored at the government’s highest levels: Black women…
New report offers guidance for pediatricians on how to prevent abuse of children with disabilities
Children with disabilities are at least three times more likely to experience abuse and neglect…
Opinion: Lessons learned — and forgotten — from the horrific epidemics of the U.S. Civil War
As the U.S. approaches 600,000 deaths from Covid-19, it is hard to fathom that this…
STAT+: Pharmalittle: J&J rivals rebuff bid to jointly study Covid-19 vaccine risks; will next-gen Covid shots be better or worse?
And so, another working week will soon draw to a close. Not a moment too…